-
April 4, 2023 Tryp Therapeutics Has Completed Psychotherapist Training for a Planned Clinical Trial to Investigate Psilocybin Therapy for IBSTryp completes their Phase 2a psilocybin for IBS clinical trial training for psychotherapists at Massachusetts...
-
July 1, 2022 Psychedelic Business Spotlight – July 1This week in psychedelic stock news: MindMed downplays delisiting fears; Red Light Holland teams with...
-
April 29, 2022 Psychedelic Business Spotlight – April 29This week in psychedelic business news: Field Trip Health splits in two, Tryp Therapeutics commences...
-
December 24, 2021 Psychedelic Business Spotlight – December 24This week in psychedelic business news: FDA green lights a new psilocybin study; MindMed commences...
-
December 23, 2021 FDA Green Lights Tryp Therapeutics’ Psilocybin Study on Binge Eating DisorderThe pharmaceutical company developing psilocybin-based compounds for diseases with unmet medical needs estimates a $2.9...
-
November 5, 2021 Psychedelic Business Spotlight: November 5This week in psychedelic business news: DEA grants Cybin a Schedule I manufacturing license; PharmaTher...
-
August 13, 2021 Psychedelic Business Spotlight: August 13, 2021This week in psychedelic business news: Psychedelics in development to treat eye diseases and stroke;...
-
July 9, 2021 Psychedelic Business Spotlight: July 9, 2021This week in psychedelic business news: It’s all about partnerships and acquisitions designed to advance...
